Results 151 to 160 of about 13,317 (169)

Echinocandins as Biotechnological Tools for Treating Candida auris Infections

open access: yesJournal of Fungi (Basel, Switzerland), 2020
Candida auris has been reported in the past few years as an invasive fungal pathogen of high interest. Its recent emergence in healthcare-associated infections triggered the efforts of researchers worldwide, seeking additional alternatives to the use of ...
Marlon Henrique Cardoso   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

International Journal of Infectious Diseases, 2020
Santiago Moreno   +2 more
exaly  

In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris

Antibiotics, 2021
Valvanera Vozmediano   +2 more
exaly  

Colistin interacts synergistically with echinocandins against

International Journal of Antimicrobial Agents, 2020
Anuradha Chowdhary, Eric Dannaoui
exaly  

Echinocandins and pneumocandins--a new antifungal class with a novel mode of action.

Journal of Antimicrobial Chemotherapy, 1997
David W. Denning
exaly  

In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris.

Antimicrobial Agents and Chemotherapy, 2017
Afsane Vaezi   +2 more
exaly  

Echinocandins vs. amphotericin B against invasive candidiasis in children and neonates: A meta-analysis of randomized controlled trials

International Journal of Antimicrobial Agents, 2019
Chih-Cheng Lai   +2 more
exaly  

Home - About - Disclaimer - Privacy